Bioblast Pharma Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$2,000.
Cash Flow
| 2017 | 0 | -2K | 0 |
|---|
ORPN Cash Flow Statement (2017 – 2017)
| 2017 | |
|---|---|
Cash at beginning of period | 0 |
Operating activities | |
Net income | -5.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 12K |
Stock-based compensation expense | 0 |
| Deferred income tax benefit | 0 |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | 567K |
Inventories | 0 |
Accounts payable | 0 |
Cash generated by operating activities | 0 |
Investing activities | |
Purchases Of Investments | 0 |
Investments In Property Plant And Equipment | -2K |
Acquisitions Net | 0 |
Cash generated by investing activities | -2K |
Financing activities | |
Common Stock Issued | 0 |
Payments for dividends | 0 |
Repurchases of common stock | 0 |
Repayments of term debt | 0 |
Cash used in financing activities | 0 |
Net Change In Cash | -2K |
Cash at end of period | -2K |